Literature DB >> 17217382

FIP1L1/PDGFRA is a molecular marker of chronic eosinophilic leukaemia but not for systemic mastocytosis.

P Valent, C Akin, D D Metcalfe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17217382     DOI： 10.1111/j.1365-2362.2007.01757.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN： 0014-2972            Impact factor:   4.686


× No keyword cloud information.
  4 in total

1.  Application of Paclitaxel-loaded EGFR Peptide-conjugated Magnetic Polymeric Liposomes for Liver Cancer Therapy.

Authors:  Zhen-Lv Lin; Jian Ding; Guo-Ping Sun; Dan Li; Shan-Shan He; Xiao-Fei Liang; Xun-Ru Huang; Jie Xie
Journal:  Curr Med Sci       Date:  2020-03-13

2.  Bone marrow mast cell burden and serum tryptase level as markers of response in patients with systemic mastocytosis.

Authors:  Alfonso Quintás-Cardama; Matjaz Sever; Jorge Cortes; Hagop Kantarjian; Srdan Verstovsek
Journal:  Leuk Lymphoma       Date:  2013-01-23

Review 3.  Advances and controversies in the diagnosis, pathogenesis, and treatment of systemic mastocytosis.

Authors:  Alfonso Quintás-Cardama; Nitin Jain; Srdan Verstovsek
Journal:  Cancer       Date:  2011-06-20       Impact factor: 6.860

4.  FIP1L1-PDGFRA molecular analysis in the differential diagnosis of eosinophilia.

Authors:  Gedeon Loules; Fani Kalala; Nikolaos Giannakoulas; Emmanouil Papadakis; Panagiota Matsouka; Matthaios Speletas
Journal:  BMC Blood Disord       Date:  2009-02-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.